Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    15519006 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
Conditions: Coronary Disease;   Ultrasonography, Interventional;   Hydroxymethylglutaryl-CoA Reductase Inhibitors
Intervention: Drug: Atorvastatin 10mg versus 40mg.
2 Active, not recruiting French Registry of Acute Coronary Syndrome
Condition: Acute Myocardial Infarction
Intervention: Other: Blood sample

Study has passed its completion date and status has not been verified in more than two years.